HIGHLIGHTS
- who: Tiong Y. Lim from the Institute of Liver Studies, King`s College Hospital, Medical Research Council (MRC) Centre for Transplantation, School of Immunology and Microbial Sciences, Faculty of Life Sciences and Medicine, King`s College London, London, UK have published the article: Low dose interleukin-2 selectively expands circulating regulatory T cells but fails to promote liver allograft tolerance in humans, in the Journal: (JOURNAL)
- what: The authors report for the first time on the use of LDIL-2 to suppress alloimmunity and promote liver allograft tolerance in humans.
SUMMARY
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.